The effect of carboxylesterase 1 (CES1) polymorphisms on the pharmacokinetics of oseltamivir in humans.

Suzaki, Yuki; Uemura, Naoto; Takada, Makoto; Ohyama, Tetsuji; Itohda, Akiko; Morimoto, Takuya; Imai, Hiromitsu; Hamasaki, Hajime; Inano, Akihiro; Hosokawa, Masakiyo; Tateishi, Masato; Ohashi, Kyoichi

Suzaki, Yuki; Uemura, Naoto; Takada, Makoto; Ohyama, Tetsuji; Itohda, Akiko; Morimoto, Takuya; Imai, Hiromitsu; Hamasaki, Hajime; Inano, Akihiro; Hosokawa, Masakiyo; Tateishi, Masato; Ohashi, Kyoichi.

Affiliation

Suzaki Y; General Clinical Research Center, Oita University Hospital, 1-1 Idaigaoka, Hasama-machi, Yufu-shi, Oita 879-5593, Japan. ysuzaki@oita-u.ac.jp

Eur J Clin Pharmacol ; 69(1): 21-30, 2013 Jan.

Article in En | MEDLINE | ID: mdl-22673926

Subject(s)

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antiviral Agents / Carboxylic Ester Hydrolases / Oseltamivir Type of study: Clinical_trials / Guideline Limits: Adult / Female / Humans / Male Language: En Journal: Eur J Clin Pharmacol Year: 2013 Document type: Article Affiliation country: Japón

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google